Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
154.73 USD | +0.08% |
|
-1.38% | -21.26% |
06-17 | Baird Adjusts Price Target on IQVIA Holdings to $159 From $161, Maintains Neutral Rating | MT |
06-11 | IQVIA Launches New AI Agents for Life Sciences and Healthcare | CI |
Company Valuation: Iqvia Holdings Inc.
Data adjusted to current consolidation scope
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 34,352 | 53,900 | 38,056 | 42,227 | 35,667 | 26,768 | - | - |
Change | - | 56.91% | -29.39% | 10.96% | -15.54% | -24.95% | - | - |
Enterprise Value (EV) 1 | 44,983 | 64,659 | 49,587 | 54,524 | 47,948 | 39,257 | 38,458 | 36,769 |
Change | - | 43.74% | -23.31% | 9.96% | -12.06% | -18.13% | -2.03% | -4.39% |
P/E ratio | 125x | 57x | 35.8x | 31.7x | 26.2x | 20.7x | 17.3x | 14.8x |
PBR | 5.71x | 9.11x | 6.6x | 7.05x | 5.94x | 4.03x | 3.47x | 2.94x |
PEG | - | 0x | 2.3x | 1.2x | 9.55x | -134.59x | 0.9x | 0.9x |
Capitalization / Revenue | 3.02x | 3.88x | 2.64x | 2.82x | 2.32x | 1.66x | 1.59x | 1.5x |
EV / Revenue | 3.96x | 4.66x | 3.44x | 3.64x | 3.11x | 2.44x | 2.28x | 2.06x |
EV / EBITDA | 18.9x | 21.4x | 14.8x | 15.3x | 13x | 10.4x | 9.54x | 8.61x |
EV / EBIT | 22.2x | 25x | 17.8x | 17.9x | 15.5x | 12.2x | 11.3x | 10.4x |
EV / FCF | 33.5x | 28.1x | 31.3x | 36.3x | 22.7x | 19.9x | 17.8x | 15.7x |
FCF Yield | 2.99% | 3.56% | 3.2% | 2.75% | 4.41% | 5.03% | 5.6% | 6.38% |
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Rate of return | - | - | - | - | - | - | - | - |
EPS 2 | 1.43 | 4.95 | 5.72 | 7.29 | 7.49 | 7.478 | 8.932 | 10.43 |
Distribution rate | - | - | - | - | - | - | - | - |
Net sales 1 | 11,359 | 13,874 | 14,410 | 14,984 | 15,405 | 16,085 | 16,858 | 17,819 |
EBITDA 1 | 2,384 | 3,022 | 3,346 | 3,569 | 3,684 | 3,791 | 4,031 | 4,272 |
EBIT 1 | 2,030 | 2,591 | 2,779 | 3,050 | 3,100 | 3,209 | 3,415 | 3,551 |
Net income 1 | 279 | 966 | 1,091 | 1,358 | 1,373 | 1,320 | 1,529 | 1,776 |
Net Debt 1 | 10,631 | 10,759 | 11,531 | 12,297 | 12,281 | 12,488 | 11,690 | 10,001 |
Reference price 2 | 179.17 | 282.14 | 204.89 | 231.38 | 196.51 | 154.73 | 154.73 | 154.73 |
Nbr of stocks (in thousands) | 191,726 | 191,040 | 185,740 | 182,500 | 181,500 | 173,000 | - | - |
Announcement Date | 10/02/21 | 15/02/22 | 10/02/23 | 14/02/24 | 06/02/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
---|---|---|---|---|---|---|
20.69x | 2.44x | 10.36x | -.--% | 26.77B | ||
38.72x | 5.64x | 19.78x | 0.88% | 48.43B | ||
158.23x | 5.39x | 87.78x | -.--% | 29.32B | ||
41.83x | 8.57x | 25.23x | 0.44% | 26.16B | ||
22.28x | 1.9x | 8.59x | 1.16% | 12.32B | ||
-45.01x | 9.94x | 2301.91x | -.--% | 11.83B | ||
15.74x | 1.79x | 9x | -.--% | 11.64B | ||
-41.42x | 15.71x | -48.86x | -.--% | 10.68B | ||
24.41x | 5.09x | 13.58x | 0.11% | 10.13B | ||
Average | 26.16x | 6.27x | 269.71x | 0.29% | 20.81B | |
Weighted average by Cap. | 42.14x | 5.88x | 168.30x | 0.37% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- IQV Stock
- Valuation Iqvia Holdings Inc.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition